Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine with Glimepiride vs Metformin in T2DM
NCT00708578Phase 4Completed
- Sponsor
- Sanofi
- Start
- May 2008
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Sanofi. Primary endpoint: Hemoglobin A1c at 24 weeks. Started May 2008; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00708578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708578.